Arcadia Investment Advisors »

Allogene Therapeutics shares owned by Arcadia Investment Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Arcadia Investment Advisors from 13F filings

Historical chart of Arcadia Investment Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Arcadia Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Arcadia Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $25 20 1.25
2025-06-30 $23 20 1.15
2025-03-31 $30 20 1.50
2024-12-31 $43 20 2.15
2024-09-30 $56 20 2.80
2024-06-30 $47 20 2.35
2024-03-31 $90 20 4.50

More positions owned by Arcadia Investment Advisors

Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Rus Top 200 Etf (IWL)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
Vanguard World Mega Cap Val Etf (MGV)
American Centy Etf Tr Avantis Us Larg (AVLC)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Ibonds Dec2026 (IBDR)
Ishares Tr Ibonds Dec25 Etf (IBDQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Ibonds 27 Etf (IBDS)
Ishares Tr Ibds Dec28 Etf (IBDT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Arcadia Investment Advisors

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics